Novavax Will Launch U.S. Phase 3 Trials Of Coronavirus Vaccine By End Of November
Novavax, one of the biotech firms that received funding from the Trump administration’s Operation Warp Speed to produce a coronavirus vaccine, announced Tuesday it plans to begin phase 3 clinical trials in the United States and Mexico by the end of November.
View the full story here: https://www.forbes.com/sites/danielcassady/2020/10/27/novavax-will-launch-us-phase-3-trials-of-coronavirus-vaccine-by-end-of-november/